Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Arolt

Showing results (191-200 of 351) with videos related to

Pageof 36
Sort By:
Journal of Anxiety Disorders|May 29, 2016
The role of treatment delivery factors in exposure-based cognitive behavioral therapy for panic disorder with agoraphobiaFlorian Weck, Florian Grikscheit, Volkmar Höfling, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 27, 2008
Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depressionKatharina Domschke, Udo Dannlowski, Patricia Ohrmann, et al.
Neuroimage. Clinical|November 1, 2017
Neurobiological and clinical effects of fNIRS-controlled rTMS in patients with panic disorder/agoraphobia during cognitive-behavioural therapySaskia Deppermann, Nadja Vennewald, Julia Diemer, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 23, 2008
Memory impairment correlates with increased S100B serum concentrations in patients with chronic schizophreniaAnya Pedersen, Markus Diedrich, Florian Kaestner, et al.
Psychiatry Research|May 22, 2010
Increased amygdala activation during automatic processing of facial emotion in schizophreniaAstrid Veronika Rauch, Maraike Reker, Patricia Ohrmann, et al.
Frontiers in Psychiatry|June 27, 2017
Support Vector Machine Analysis of Functional Magnetic Resonance Imaging of Interoception Does Not Reliably Predict Individual Outcomes of Cognitive Behavioral Therapy in Panic Disorder with AgoraphobiaBenedikt Sundermann, Jens Bode, Ulrike Lueken, et al.
Journal of Psychiatry & Neuroscience : JPN|June 14, 2017
Prefrontal brain responsiveness to negative stimuli distinguishes familial risk for major depression from acute disorderNils Opel, Ronny Redlich, Dominik Grotegerd, et al.
Plos One|July 1, 2016
Hypermethylation of FOXP3 Promoter and Premature Aging of the Immune System in Female Patients with Panic Disorder?Martina Prelog, Deborah Hilligardt, Christian A Schmidt, et al.
BMC Neuroscience|November 14, 2013
Automatic amygdala response to facial expression in schizophrenia: initial hyperresponsivity followed by hyporesponsivityThomas Suslow, Christian Lindner, Udo Dannlowski, et al.
Psychoneuroendocrinology|January 17, 2017
Serum brain-derived neurotrophic factor and stability of depressive symptoms in coronary heart disease patients: A prospective studyStella L Kuhlmann, Mira Tschorn, Volker Arolt, et al.
Pageof 36

Showing results (191-200 of 351) with videos related to

Sort By:
Pageof 36
Journal of Anxiety Disorders|May 29, 2016
The role of treatment delivery factors in exposure-based cognitive behavioral therapy for panic disorder with agoraphobiaFlorian Weck, Florian Grikscheit, Volkmar Höfling, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 27, 2008
Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depressionKatharina Domschke, Udo Dannlowski, Patricia Ohrmann, et al.
Neuroimage. Clinical|November 1, 2017
Neurobiological and clinical effects of fNIRS-controlled rTMS in patients with panic disorder/agoraphobia during cognitive-behavioural therapySaskia Deppermann, Nadja Vennewald, Julia Diemer, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 23, 2008
Memory impairment correlates with increased S100B serum concentrations in patients with chronic schizophreniaAnya Pedersen, Markus Diedrich, Florian Kaestner, et al.
Psychiatry Research|May 22, 2010
Increased amygdala activation during automatic processing of facial emotion in schizophreniaAstrid Veronika Rauch, Maraike Reker, Patricia Ohrmann, et al.
Frontiers in Psychiatry|June 27, 2017
Support Vector Machine Analysis of Functional Magnetic Resonance Imaging of Interoception Does Not Reliably Predict Individual Outcomes of Cognitive Behavioral Therapy in Panic Disorder with AgoraphobiaBenedikt Sundermann, Jens Bode, Ulrike Lueken, et al.
Journal of Psychiatry & Neuroscience : JPN|June 14, 2017
Prefrontal brain responsiveness to negative stimuli distinguishes familial risk for major depression from acute disorderNils Opel, Ronny Redlich, Dominik Grotegerd, et al.
Plos One|July 1, 2016
Hypermethylation of FOXP3 Promoter and Premature Aging of the Immune System in Female Patients with Panic Disorder?Martina Prelog, Deborah Hilligardt, Christian A Schmidt, et al.
BMC Neuroscience|November 14, 2013
Automatic amygdala response to facial expression in schizophrenia: initial hyperresponsivity followed by hyporesponsivityThomas Suslow, Christian Lindner, Udo Dannlowski, et al.
Psychoneuroendocrinology|January 17, 2017
Serum brain-derived neurotrophic factor and stability of depressive symptoms in coronary heart disease patients: A prospective studyStella L Kuhlmann, Mira Tschorn, Volker Arolt, et al.
Pageof 36